NORMOSANG Trademark

Trademark Overview

On Wednesday, October 12, 2011, a trademark application was filed for NORMOSANG with the United States Patent and Trademark Office. The USPTO has given the NORMOSANG trademark a serial number of 79104751. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, March 1, 2019. This trademark is owned by RECORDATI ORPHAN DRUGS. The NORMOSANG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing hemin complexes for the treatment of metabolic diseases
normosang

General Information

Serial Number79104751
Word MarkNORMOSANG
Filing DateWednesday, October 12, 2011
Status709 - CANCELLED - SECTION 71
Status DateFriday, March 1, 2019
Registration Number4177652
Registration DateTuesday, July 24, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 8, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations containing hemin complexes for the treatment of metabolic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 1, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRecordati Rare Diseases
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressFR
Party NameRECORDATI ORPHAN DRUGS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPUTEAUX F92800
FR
Party NameRECORDATI ORPHAN DRUGS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPUTEAUX F92800
FR
Party NameRECORDATI ORPHAN DRUGS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPUTEAUX F92800
FR

Trademark Events

Event DateEvent Description
Thursday, January 18, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 24, 2023CHANGE OF OWNER RECEIVED FROM IB
Friday, December 27, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Friday, November 22, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, November 22, 2019INVALIDATION PROCESSED
Friday, November 1, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 1, 2019CANCELLED SECTION 71
Thursday, September 14, 2017INTERNATIONAL REGISTRATION RENEWED
Monday, July 24, 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, July 21, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, January 21, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 27, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, March 3, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 26, 2012FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 26, 2012FINAL DISPOSITION PROCESSED
Wednesday, October 24, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 24, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, May 8, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 8, 2012PUBLISHED FOR OPPOSITION
Wednesday, April 18, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 31, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, March 31, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 29, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 29, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 22, 2012ASSIGNED TO LIE
Friday, March 9, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 25, 2012REFUSAL PROCESSED BY IB
Monday, February 6, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, February 6, 2012REFUSAL PROCESSED BY MPU
Friday, February 3, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 2, 2012NON-FINAL ACTION WRITTEN
Tuesday, January 31, 2012ASSIGNED TO EXAMINER
Saturday, November 26, 2011APPLICATION FILING RECEIPT MAILED
Tuesday, November 22, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 18, 2011SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

normosang treatment metabolic diseases complexes hemin preparations containing pharmaceutical